Figure 3
From: c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
c-MET inhibitors significantly increased cellular apoptosis in OCCC cell lines ES2 and RMG1.
Cells treated with (A) SU11274 or (B) crizotinib showed significantly more apoptosis as assessed by FACS analysis (error bar represents s.e.m. *p < 0.001, **p < 0.010, ***p < 0.050).
